Lv5
990 积分 2026-01-06 加入
P0033 Repositioning dual GLP-1/GIP receptor agonists for the treatment of colitis and colitis-associated cancer (CAC)
11天前
已完结
Peptide Hormones and Bile Acids Shaping Immune Tolerance of the Liver: Implications and Applications
11天前
已完结
Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: A review of current evidence and future directions
16天前
已完结
REPOSITIONING DUAL GLP-1/GIP RECEPTOR AGONISTS FOR THE TREATMENT OF COLITIS AND COLITIS-ASSOCIATED TUMORIGENESIS
17天前
已完结
Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery
17天前
已关闭
Peptide Hormones and Bile Acids Shaping Immune Tolerance of the Liver: Implications and Applications
17天前
已完结
Anorexigenic and anti-inflammatory signaling pathways of semaglutide via the microbiota–gut––brain axis in obese mice
18天前
已完结
The role of the incretin GIP in inflammation
18天前
已完结
Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review
18天前
已完结
Hit identification in ultra large virtual screening: an integrative review and future challenges
22天前
已完结
皖公网安备34019202002308
